Covid-19, Pandemic.
vaccine will, at best, be available months later than some had hoped. J&J became the fourth COVID-19 vaccine candidate but it will not likely become available until early 2021. Novavax launched a phase 3 trial for it’s protein-based vaccine in the UK. Many experts believe they have one of the most